Investigate Nasal Colonize Staphylococcus Species Biofilm Produced

dc.contributor.author Demir, C.
dc.contributor.author İnanç, B.B.
dc.date.accessioned 14.07.201910:49:13
dc.date.accessioned 2019-07-16T20:45:39Z
dc.date.accessioned 2025-09-17T14:28:06Z
dc.date.available 14.07.201910:49:13
dc.date.available 2019-07-16T20:45:39Z
dc.date.available 2025-09-17T14:28:06Z
dc.date.issued 2015
dc.description.abstract Aim: 127 S.aureus and 65 CoNS strains were isolated from patients noses’. To produce a biofilm ability was investigated using three different methods. Slime-positive and negative staphylococcies’ resistance were evaluated against different antibiotics. Material and Method: Swap samples puted 7% blood agar. Staphylococcus aureus and coagulase-negative staphylococci (CoNS) isolates biofilm produced ability were investigated using Congo Red Agar (CRA), microplates (MP) and Standard Tube (ST) methods. In addition to that, presence of antibiotic resistance of the staphylococcal isolates are determined agar disc diffusion method. Results: The rate of biofilm produc-ing Staphylococcus spp strains was found to be 72.4%, 67.7%, and 62.9%, respectively with CRA, MP, and ST tests. There was no significant relationship among the tests (p>0.05). In addition, antibiotic resistance of Staphylococcus spp. against various antibiotics was also determined by the agar disk dif-fusion method. Resistance rates of biofilm positive (BP) Staphylococcus spp for penicilin G, ampicilin, amocycilin/clavulanic acid, tetracyclin, eritromycin, gentamycin, and enrofloxacin 71.7%, 69.7%, 6.2%, 20.7%, 21.4%, 1.4%, and 0.7%, respectively. Resistance rates of biofilm negative (BN) spp for 42.6%, 23.4%, 4.3%, 14.9%, 19.1%, 0.0%, 0.0% respectively. All Staphylococcus isolates were found to be susceptible to vancomycin and teicaplonin. Although BP strains antibiotic resistance rates were observed higher than BN strains. But resistance rates were not found statistically significant (p>0.05). Discus-sion: CRA is the reliablity and specifity method to determine Staphylococcus spp. biofilm produce ability. © 2015, Journal of Clinical and Analytical Medicine. All rights reserved. en_US
dc.identifier.doi 10.4328/JCAM.2082
dc.identifier.issn 1309-0720
dc.identifier.scopus 2-s2.0-84928555755
dc.identifier.uri https://doi.org/10.4328/JCAM.2082
dc.identifier.uri https://hdl.handle.net/20.500.12514/9401
dc.indekslendigikaynak Web of Science en_US
dc.indekslendigikaynak Scopus en_US
dc.indekslendigikaynak TR-Dizin en_US
dc.language.iso tr en_US
dc.publisher Journal of Clinical and Analytical Medicine en_US
dc.relation.ispartof Journal of Clinical and Analytical Medicine en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Antibiotic Resistance en_US
dc.subject Biofilm en_US
dc.subject Coagulase en_US
dc.subject Staphylococcus Aureus en_US
dc.title Investigate Nasal Colonize Staphylococcus Species Biofilm Produced en_US
dc.title.alternative Nazal Kolonize Stafilokok Türlerinde Biyofilm Üretiminin Araştırılması en_US
dc.type Article en_US
dspace.entity.type Publication

Files